Nothing Special   »   [go: up one dir, main page]

Torres-Acosta et al., 2022 - Google Patents

Automated liquid-handling operations for robust, resilient, and efficient bio-based laboratory practices

Torres-Acosta et al., 2022

View HTML
Document ID
17186461376704924398
Author
Torres-Acosta M
Lye G
Dikicioglu D
Publication year
Publication venue
Biochemical Engineering Journal

External Links

Snippet

Increase in the adoption of liquid handling devices (LHD) can facilitate experimental activities. Initially adopted by businesses and industry-based laboratories, the practice has also moved to academic environments, where a wide range of non-standard/non-typical …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G06F19/366—Acquisition of data related to laboratory tests, e.g. special identifiers for examination containers
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00178—Special arrangements of analysers
    • G01N2035/00326—Analysers with modular structure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00722—Communications; Identification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids

Similar Documents

Publication Publication Date Title
Torres-Acosta et al. Automated liquid-handling operations for robust, resilient, and efficient bio-based laboratory practices
Chen et al. Single-cell analysis at the threshold
Valihrach et al. Platforms for single-cell collection and analysis
Bonaguro et al. A guide to systems-level immunomics
González-Cabaleiro et al. Heterogeneity in pure microbial systems: experimental measurements and modeling
Millington et al. Digital microfluidics comes of age: high-throughput screening to bedside diagnostic testing for genetic disorders in newborns
US20160144358A1 (en) Dynamic Lab on a Chip Based Point-Of-Care Device For Analysis of Pluripotent Stem Cells, Tumor Cells, Drug Metabolites, Immunological Response, Glucose Monitoring, Hospital Based Infectious Diseases, and Drone Delivery Point-of-Care Systems
Carrondo et al. How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?
Love et al. Microtools for single-cell analysis in biopharmaceutical development and manufacturing
US9977862B2 (en) Bioprocess method and system
Liu et al. Microfluidic platforms for single-cell protein analysis
Wilson et al. Innovative technological advancements in laboratory medicine: Predicting the lab of the future
US20200199568A1 (en) Methods for experimental evolution of natural and synthetic microbes
Di Meo et al. What is wrong with clinical proteomics?
Wu et al. An intelligent automation platform for rapid bioprocess design
Kim Overview of the microfluidic diagnostics commercial landscape
Neubauer et al. Bioprocess development in the era of digitalization
Zucchelli et al. Highly versatile cloud-based automation solution for the remote design and execution of experiment protocols during the COVID-19 pandemic
Linshiz et al. The fusion of biology, computer science, and engineering: towards efficient and successful synthetic biology
Sanderson et al. PlasmoTron: an open-source platform for automated culture of malaria parasites
Pavan Setting up an automated biomanufacturing laboratory
Hood A systems approach to medicine will transform healthcare
Häkkinen et al. Implementation of an Open Source Software solution for Laboratory Information Management and automated RNAseq data analysis in a large-scale Cancer Genomics initiative using BASE with extension package Reggie
Kranjc Entrepreneur's Perspective on Laboratories in 10 Years
Whitford Bioprocess Intensification: Technologies and Goals William G. Whitford